Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.45 USD | -0.27% | -2.91% | +16.58% |
Jun. 07 | BWX Technologies' Unit Submits Drug Master File for Actinium-225 to FDA | MT |
May. 07 | BWX Technologies, Inc. Appoints Nicole W. Piasecki to the Governance Committee | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.34 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.51 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Aerospace & Defense
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.58% | 8.18B | B- | ||
+28.49% | 143B | C | ||
+15.20% | 81.94B | B | ||
-6.00% | 65.12B | A- | ||
+26.30% | 53.4B | B | ||
+54.57% | 48.62B | A- | ||
+5.36% | 42.09B | B+ | ||
+71.18% | 38B | C- | ||
+84.95% | 25B | B | ||
+53.97% | 24.78B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BWXT Stock
- Ratings BWX Technologies, Inc.